ea0026s15.2 | Emerging therapies in type 2 diabetes | ECE2011
Stewart P , Cooper M , Lavery G , Tomlinson J
ea0019oc12 | Neuroendocrine and Steroids | SFEBES2009
Semjonous N , Lavery G , Walker E , Stewart P
ea0019oc19 | Cardiovascular metabolism | SFEBES2009
Gathercole L , Buljalska I , Stewart P , Tomlinson J
ea0019p330 | Steroids | SFEBES2009
Tiganescu A , Dekker P , Mayes A E , Stewart P , Walker E A
ea0011p210 | Clinical practise and governance | ECE2006
Ciin LCH , Narayanan P , Stewart F , Heald A , Dornan T
ea0009oc3 | Oral Communication 1: Diabetes and metabolism | BES2005
Gathercole L , Bujalska I , Stewart P , Tomlinson J
ea0009p15 | Diabetes and metabolism | BES2005
Quinkler M , Bujalska I , Tomlinson J , Smith D , Stewart P
ea0009p17 | Diabetes and metabolism | BES2005
Lavery G , Draper N , Parker K , Walker E , Stewart P
ea0009p130 | Steroids | BES2005
Walker O , Walker E , Stewart P , Ride J
ea0007p87 | Endocrine tumours and neoplasia | BES2004
Ayuk J , Stewart S , Sheppard M , Stewart P